Black Diamond Therapeutics (BDTX) EPS (Basic) (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted EPS (Basic) of -$0.2 for Q1 2026, up 35.65% on a QoQ basis from -$0.31 in Q4 2025, and down 120.85% year-over-year from $0.95 in Q1 2025.
Black Diamond Therapeutics (BDTX) EPS (Basic) (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.2 for Q1 2026.
- Quarterly EPS (Basic) fell 120.85% year-over-year to -$0.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 (down 42.55% YoY) and the FY2025 annual result came in at -$1.89, up 48.99% from the prior year.
- EPS (Basic) was -$0.2 for Q1 2026 at Black Diamond Therapeutics, up from -$0.31 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.95 in Q1 2025 and bottomed at -$1.58 in Q3 2022.
- A 5-year average of -$0.52 and a median of -$0.49 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) jumped 338.72% — and 2026, when it tumbled 120.85%.
- Black Diamond Therapeutics' EPS (Basic) stood at -$0.61 in 2022, then climbed by 19.64% to -$0.49 in 2023, then jumped by 30.44% to -$0.34 in 2024, then increased by 9.68% to -$0.31 in 2025, then jumped by 35.65% to -$0.2 in 2026.
- Business Quant data shows BDTX's EPS (Basic) at -$0.2 in Q1 2026, -$0.31 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.31 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.44 |
| Jun 30, 2024 | -0.90 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.49 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.84 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -1.58 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -0.72 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -1.19 |
| Jun 30, 2021 | -1.43 |